Measurements of urine leptin levels in OSA patients Source: Eur Respir J 2003; 22: Suppl. 45, 90s Year: 2003
Reproducibility, reliability and diurnal variation of standardized exhaled NO measurements with NIOX™ in healthy and asthmatic children and adults made in routine clinical practice Source: Eur Respir J 2001; 18: Suppl. 33, 4s Year: 2001
Meaning of diurnal and nocturnal CO2 measurement as a parameter for treatment assessment in NIV Source: Annual Congress 2013 –The challenges and measures in home ventilation Year: 2013
Leptin daytime urine secretion corresponds to OSA severity Source: Eur Respir J 2004; 24: Suppl. 48, 566s Year: 2004
Blood pressure response to CPAP treatment in subjects with obstructive sleep apnoea: the predictive value of 24-h ambulatory blood pressure monitoring Source: Eur Respir J, 50 (4) 1700651; 10.1183/13993003.00651-2017 Year: 2017
Screening of sleep apnoea from values obtained by monitoring of blood pressure and heart rate variability Source: Eur Respir J 2001; 18: Suppl. 33, 89s Year: 2001
Impact of continuous, non-invasive blood pressure (BP) measurement on sleep quality during polysomnography (PSG) Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA Year: 2012
Measurement duration impacts variability but not impedance measured by the forced oscillation technique in healthy, asthma and COPD subjects Source: ERJ Open Res 2016: 00094-2015 Year: 2016
Alternative method for non-invasive automatic positive airway pressure therapy in OSAS patients Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II Year: 2011
Precision and utility of an ambulatory sleep diagnostic sytem based on peripheral arterial tonometry (pat) compared to simultaneous polysomnography in patients with OSAS Source: Annual Congress 2009 - Diagnostic aspects in obstructive sleep apnoea Year: 2009
Is the daytime CPAP titration effective for determining therapeutic pressure levels in OSA patients? Source: Eur Respir J 2001; 18: Suppl. 33, 417s Year: 2001
Morning microalbuminuria, as a prognostic factor to predict blood pressure increase in patients with sleep aponea syndrome Source: Eur Respir J 2003; 22: Suppl. 45, 90s Year: 2003
Is FEV1 better than PEF at detecting asthmatic changes in diurnal variation? Source: Annual Congress 2011 - The work environment in the clinic Year: 2011
Nasal pressure variation measurement with a microphone: A new low cost tool for diagnosis of obstructive sleep apnoea in a resource poor setting Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA Year: 2012
The measurement of arterial blood gas lactate levels as a marker of tissue hypoxia in OSAS and overlap syndrome Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007
Inter-laboratory variability in the measurement of lung function - contribution of volume calibration errors Source: Eur Respir J 2004; 24: Suppl. 48, 183s Year: 2004
Importance of sleep stage- and body position-dependence of sleep apnoea in determining benefits to auto-CPAP therapy Source: Eur Respir J 2001; 18: 170-175 Year: 2001
Correlation of morning plasma fibrinogen levels and polysomnography indices in children with mild to moderate sleep-disordered breathing Source: Eur Respir J 2003; 22: Suppl. 45, 391s Year: 2003
Validation of a method to accurately measure total lung capacity with the single breath technique in normal subjects and in patients with airway obstruction Source: Annual Congress 2008 - Beyond spirometry: the skills behind lung function testing Year: 2008
Influence of gas concentration and measurement interval on the reproducibility of non-invasive cardiac output determination by inert gas rebreathing in pulmonary healthy patients Source: Annual Congress 2011 - Innovative methods in exercise testing Year: 2011